SEC Form 4 · accession 0000939767-18-000055
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack L Wyszomierski
Director
Period of report
Apr 16, 2018
Accepted (ET)
Apr 18, 2018 · 8:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 16, 2018 | M | 15,000 | $7.97 | A | 93,803 | D | |
| Common Stock | Apr 16, 2018 | M | 15,000 | $11.66 | A | 108,803 | D | |
| Common StockF3 | Apr 16, 2018 | S | 14,959 | $20.25 | D | 93,844 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F4 | $7.97 | Apr 16, 2018 | M | 15,000 | D | May 2, 2008 | May 1, 2018 | Common Stock | 15,000 | 0 | D |
| Option (right to buy)F5 | $11.66 | Apr 16, 2018 | M | 15,000 | D | May 19, 2011 | May 18, 2018 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2018.
- F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.04 to $20.74. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- F4The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008.
- F5The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney